Phase 2 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with a high-grade brain tumour called WHO Grade IV glioma, as defined by a specific Chinese cancer treatment guideline.
- People whose tumour has come back (recurred) after surgery, confirmed by a brain MRI scan.
- People who have at least one tumour that can be measured on a brain scan, according to a standard set of assessment criteria.
- People aged 18 to 70 years old (any gender).
- People whose steroid medication (dexamethasone), if taken for brain swelling caused by the tumour, has been at a stable low dose (under 6 mg per day) in the 7 days before joining the trial (confirm with trial site for specific dosing rules).
- People with a physical functioning score showing they are able to carry out at least limited self-care — a Karnofsky score of 40 or above, or a WHO performance score of 3 or below.
- People whose blood counts, liver function, and kidney function fall within acceptable ranges on tests taken within 14 days before treatment (confirm with trial site for specific values).
- People who are able to receive electroacupuncture treatment and are willing to attend consistently.
- People who are fully conscious, able to feel and identify pain, and can communicate at a basic level.
- People who have read and signed the informed consent form and are willing to take part voluntarily.
Who may not be able to join:
- People experiencing seizures that cannot be controlled.
- People who are currently enrolled in another clinical trial, or who finished another clinical trial less than one month ago.
- People who have previously received treatment with paclitaxel or similar drugs.
- People who have a severe allergic reaction to paclitaxel or similar substances.
- People who are pregnant or breastfeeding.
- People with conditions that affect thinking or memory, such as congenital dementia, or people with alcohol dependence, drug addiction, or misuse of mind-altering substances.
- People who have a skin infection at the location where acupuncture needles would be placed.
- People who have metal objects inside their body (such as implants or fragments).
- People who are unable to have a contrast-enhanced brain MRI scan.
- People with other serious medical conditions, mental health disorders, or abnormal test results that the trial doctor believes could increase health risks or affect the trial results.
- People who are currently receiving other cancer treatments at the same time, such as chemotherapy, radiotherapy, targeted therapy, or immunotherapy.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-13858028101
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
4-month progression-free survival rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.